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Open access un1. Introduction
Trousseau's syndrome, unexplained thrombotic events that precede
the diagnosis of an occult visceral malignancy or appear concomitantly
with a tumor, was ﬁrst recognized by Trousseau in 1865 (Trousseau,
1865). Historically, pancreatic carcinoma has been associated with the
greatest risk of thrombo-embolic events with a 57% incidence rate
(Viselli et al., 1993). Aside from pancreatic malignancy, tumors in
other organs such as breast, lung, and colon carcinomas may also have
increased risks (Sack et al., 1977). In a review of literature, Sack et al.
showed seven reported cases of Trousseau's syndrome related to ovarian
carcinoma, which represented 3.8% of all reported cases of thrombo-
embolic events associated with malignancies (Sack et al., 1977).
Coagulopathy usually occurs in patients with advanced or recurrent
ovarian carcinomas, which may result in deep venous thrombosis
(DVT) of the lower extremities inmost ovarian cancer patients and sub-
sequently, pulmonary emboli in some cases (Viselli et al., 1993). In
addition to the lower extremities and lung, there are reports of ovarian
malignancy causing thrombo-embolism in other tissues or organs,
including the brain, heart, kidneys, and spleen (Nakayama et al., 2002).bstetrics and Gynecology, National Taiwan
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der CC BY-NC-ND license .Here is a rare case of malignant struma ovarii with cerebral ische-
mic stroke in themiddle cerebral artery (MCA). The patient underwent
anti-thrombotic therapy followed by surgical intervention. However,
repeated episodes of ischemic strokes and DVTs occurred and she
died of respiratory failure due to brainstem infarction one month
after surgery.2. Case report
A 66-year-old woman with hypertension under good medical con-
trol complained of lower abdominal distention for several days. During
consultation with a general physician, a fetal-head sized pelvic tumor
was palpated on physical examination. The mass originated from
ovary and was highly suspected on ultrasonography; therefore, the
patient was referred for further work-up. A series of studies including
blood testing, imaging studies, and endoscopy for gastro-intestinal ex-
aminationswas conducted. Except for elevated serumcarcinoma antigen
125 (CA-125, 3786.0 U/ml), all of the blood test results were within
normal limits. Abdominal and pelvic magnetic resonance imaging
(MRI) exhibited a 10 cm left adnexal tumor with heterogeneous com-
ponents, which was suspected to be ovarian malignancy (Fig. 1). No
other abnormalities of the gastro-intestinal tract were noted by endo-
scopic examination.
After completing the diagnostic studies, the patient suddenly suf-
fered from right hemianopia, rightward gaze palsy, and right hemiplegia
with global aphasia. The perfusion evaluation of emergency brain com-
puted tomography (CT) revealed occlusion of the left MCA with large
territory of cerebral damage (Fig. 2). Studies of coagulation factors,
including ﬁbrinogen (159.3 mg/dl; normal ranges 163.5–362.7 mg/dl),
ﬁbrinogen and ﬁbrin degradation product (42.5 μg/ml; normal range
b4.1 μg/ml), and ﬁbrinogen and ﬁbrin degradation product-D dimer
(27.05 μg/ml; normal range b2.09 μg/ml) showed hyper-coagulation
status. However, ultrasonographic duplex study of the carotid vessels
and trans-thoracic echocardiography did not identify any deﬁnite
thrombus formation.
After two weeks of medical control in intensive care unit to balance
her vascular and intracranial pressure, the aphasia and right lower limb
weakness improved by rehabilitation. However, the tenderness of the
left leg becamemore severe. Venous Doppler ultrasonography revealed
thrombi formation over the bilateral lower limbs, especially in left leg.
Fig. 1. Pre-operative magnetic resonance imaging study of the pelvis revealed a pelvic
mass approximately 10 cm in diameter, with cystic (star) and solid (arrows)
components.
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the left MCA but without progression when referenced with previous
CT studies. Thus, anti-coagulation therapy as suggested by the hema-
tologist was started with low molecular weight heparin by subcuta-
neous injection.
After the leg tenderness subsided, staging surgery, including peri-
toneal washing cytology, total abdominal hysterectomy, bilateral
salpingo-oophorectomy, left pelvic lymphadenectomy, and infra-colic
omentectomy was performed. Peritoneal tumor seeding or tumor me-
tastasis to adjacent organs was not noted. Optimal debulking surgery
without gross residual tumor was performed. Microscopic examination
of the left ovary showed predominant thyroid tissue. Tumor cells form-
ing fused glands or irregular nests adjacent to the benign thyroid tissueFig. 2. (A–C) Perfusion CT scan of the patient after the ﬁrst episode of ischemic stroke reveale
left temporal and parietal lobes.in a small area demonstrated hyper-chromatic and pleomorphic nuclei,
eosinophilic cytoplasm, and evident mitoses. Furthermore, there was
lymph node metastasis (Fig. 3). Based on the FIGO criteria of ovarian
carcinoma, her tumor was diagnosed as malignant struma ovarii with
FIGO stage IIIC disease (Johnson et al., 1999). Results of the thyroid
function tests, including T3, free T4, and TSH, were all within normal
ranges.
The patient's consciousness and right-sided weakness deteriorated
two weeks after surgery. Brain CT scan showed ischemic stroke of the
left MCA with enlarging territory and infarction of the right occipital
lobe, from which the patient never recovered. Two weeks later, a third
episode of ischemic stroke occurred. She died of respiratory failure
due to brainstem infarction one month after surgery.
3. Discussion
Thrombo-embolic manifestation is a very rare event associated
with malignant struma ovarii. To date, there is no thrombo-embolic
manifestation associated with malignant struma ovarii reported in
literature (http://www.ncbi.nlm.nih.gov/pubmed with the keyword
of malignant struma ovarii). This patient may be the ﬁrst case of
Trousseau's syndrome developed in association with malignant struma
ovarii. Struma ovarii is a variant of dermoid tumors of the ovary in
which the component of thyroid tissues is the major constituent
(Kempers et al., 1970). Struma ovarii comprises 2.7% of all ovarian der-
moid tumors and very rarely presents in a malignant form, occurring in
0.3–5% of all struma ovarii tumors (Gould et al., 1983). Previous reports
have shown that patients with struma ovarii are largely asymptomatic
or are accompanied by non-speciﬁc symptoms similar to other ovarian
neoplasms. Despite disorders of blood coagulation in untreated neo-
plastic diseases, overt clinically signiﬁcant thrombo-embolic events re-
main relatively uncommon. Of the cases associated with malignancy,
3.8% are ovarian in origin (Sack et al., 1977).
Coagulopathy usually occurs in patients with advanced or recurrent
ovarian carcinomas, which may result in DVT of the lower extremitiesd occlusion of the left MCA. (D–F) The large involved territory (arrows) extended to the
Fig. 3. (A) The gross picture of the left ovarian tumor, which was composed of a predominantly cystic lesion with diffuse calciﬁcation on the cystic wall. A small, tan-to-brown,
gelatinous and solid area (star) was also noted on the cystic wall. (B) Microscopic ﬁndings of the solid area revealed an area of malignant neoplastic cells (star) forming fused glands
or irregular nests intimately mixed with the adjacent benign thyroid tissue (arrow) (hematoxylin and eosin, original magniﬁcation ×200). (C) Microscopic ﬁndings of the meta-
static cancer cells in the lymph node showed identiﬁable cancer cells (arrow) in the lymph node (hematoxylin and eosin, original magniﬁcation ×400).
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1987). There are very few reports of ovarian malignancy causing
thrombo-embolism in organs other than the lower extremities and
lungs, as in the current case report (Nakayama et al., 2002). Several
mechanisms formalignancy-coagulopathy have been proposed, includ-
ing release of thromboplastin-like substances, ﬁbrin deposition, direct
factor X activation by tumor proteases, and destruction of endothelial
cells with subsequent activation by sub-endothelial tissue or tissue fac-
tors (Dvorak, 1987). Furthermore, thrombo-embolic disease like the
one in this patient can be due to embolization of free clusters of meta-
static malignant cells. Such a hypothesis has been demonstrated in the
report of Begin and Raptis, which involved fatal diffuse pulmonary car-
cinomatous embolization in an ovarian cancer patient (Begin and
Raptis, 1991). As such, the thrombo-embolic events of the current pa-
tient may be the result of embolization of malignant cell clusters rather
than her well-controlled hypertension, because her tumor cells metas-
tasized to the lymph node via lympho-vascular route that can also
cause thrombi formation.
A hyper-coagulation state is a frequent complication in advanced
cancer, ranging from asymptomatic abnormal coagulation tests to mas-
sive clinical thrombo-embolism (Johnson et al., 1999). Malignancy-
associated hyper-viscosity is characterized by normal or lowhematocrit
and hemoglobin concentrations, elevated platelet count, prolonged
prothrombin or thrombin time, and increased clotting factor turnover
(Sack et al., 1977). However, blood cell counts, hemoglobin, hematocrit,
and platelet count were all within normal ranges in this patient when
the ischemic stroke occurred. Neither the prothrombin time nor the
thrombin time was prolonged and only abnormally increased ﬁbrino-
gen and ﬁbrin degradation product, and ﬁbrinogen and ﬁbrin degrada-
tion product-D dimer were noted.
The primary approach for treating malignancy-related Trousseau's
syndrome is the elimination of the causative tumor regardless of under-
lying mechanisms. Treatment directed to the underlying malignancy
can also signiﬁcantly improve the hyper-coagulable state. If the disease
still progresses despite treatment, adequate anti-coagulant therapiesare necessary for these patients (Sack et al., 1977). However, a hallmark
of Trousseau's syndrome is that breakthrough thrombo-embolic events
may occur despite satisfactory levels of anti-coagulation, especially
when these patients have persistent, progressive, or recurrent ovarian
cancer (Viselli et al., 1993). In the present patient, even though anti-
coagulant therapies and complete removal of the tumor were per-
formed, the thrombo-embolic process could not be adequately con-
trolled and eventually led to death.
For advanced malignant struma ovarii, DeSimone et al. reported
that surgical resection accompanied by radioiodine therapy could im-
prove clinical outcome (DeSimone et al., 2003). However, the optimal
treatment modality remains to be established. For advanced malig-
nant struma ovarii patients with Trousseau's syndrome, as in this
case, adjuvant treatment can be started more immediately post-
surgery to aggressively correct the coagulopathy, if possible.
In summary, ischemic stroke as the presenting symptom of ad-
vanced ovarian cancer is rare. Physicians should take into consideration
the possibility that stroke can sometimes be themanifestation of under-
lying malignancy. Patients with cerebral infarct of unknown etiology
should be investigated for a malignant process. When the diagnosis of
malignancy is conﬁrmed, a combination of anti-neoplastic and anti-
coagulant therapy should be undertaken as soon as possible to treat
and correct the malignancy-associated coagulopathy.
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